The basis of complications in the context of SARS-CoV-2 infection: Pathological activation of ADAM17
Description
The virulence of SARS-CoV-2 decreases with increasing infectivity, the primary approaches for antiviral treatments will be preventing or minimizing the complications resulting from virus infection. ADAM metallopeptidase domain 17 (ADAM17) activation
